{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:10Z","timestamp":1790820610862,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008648","name":"Krajowy Naukowy Osrodek Wiodacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bioactmat.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T06:12:38Z","timestamp":1603519958000},"page":"1163-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-8007","authenticated-orcid":false,"given":"Anna","family":"Jaromin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Parapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Basilico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Zaremba-Czogalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Lewi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zag\u00f3rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Tyliszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Grzeszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"\u0141ukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Gubernator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2020.10.004_bib1","series-title":"WHO World Malaria Report 2019","year":"2019"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","article-title":"Drug-resistant malaria: molecular mechanisms and implications for public health","volume":"585","author":"Petersen","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.09.15","article-title":"Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria","volume":"4","author":"Roepe","year":"2009","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib4","series-title":"WHO Eliminating Malaria: Learning from the Past, Looking Ahead","isbn-type":"print","year":"2011","ISBN":"https:\/\/id.crossref.org\/isbn\/9789241502504"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-Resistant Plasmodium falciparum malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib8","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1111\/j.1742-4658.2007.05999.x","article-title":"Drug - resistant malaria - an insight","volume":"274","author":"Hyde","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalh\u00e3es","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","article-title":"Advances in nanomedicines for malaria treatment","volume":"201\u2013202","author":"Aditya","year":"2013","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actatropica.2019.04.020","article-title":"Nano-facilitated drug delivery strategies in the treatment of plasmodium infection","volume":"195","author":"Puttappa","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2012.04.010","article-title":"Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice","volume":"131","author":"Aditya","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01796-15","article-title":"Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria","volume":"60","author":"Rajendran","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib16","first-page":"3865","article-title":"Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles","volume":"9","author":"Omwoyo","year":"2014","journal-title":"Int. J Nanomed."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12936-018-2302-9","article-title":"In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles","volume":"17","author":"Muga","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/IJN.S76317","article-title":"Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice","volume":"10","author":"Melariri","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2008.06.012","article-title":"Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria","volume":"362","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2008.06.021","article-title":"Development of SMEDDS using natural lipophile: application to beta-Artemether delivery","volume":"362","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cocis.2005.06.004","article-title":"Nano-emulsions","volume":"10","author":"Solans","year":"2005","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/03639045.2017.1342654","article-title":"Review and analysis of FDA approved drugs using lipid-based formulations","volume":"43","author":"Savla","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"IInt. J. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/21691401.2014.887018","article-title":"Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether","volume":"43","author":"Laxmi","year":"2015","journal-title":"Artif Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2011.12.031","article-title":"Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies","volume":"431","author":"Borhade","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib26","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/cr020059j","article-title":"Isolation and synthesis of biologically active carbazole alkaloids","volume":"102","author":"Kn\u00f6lker","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib27","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/cr200447s","article-title":"Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids","volume":"112","author":"Schmidt","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejmech.2015.02.059","article-title":"Biological potential of carbazole derivatives","volume":"94","author":"G\u0142uszy\u0144ska","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpddr.2017.03.007","article-title":"Novel carbazole aminoalcohols as inhibitors of \u03b2-hematin formation: antiplasmodial and antischistosomal activities","volume":"7","author":"Wang","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib30","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1021\/acs.jmedchem.6b00591","article-title":"Inhibition of Plasmodium falciparum Hsp90 contributes to the antimalarial activities of aminoalcohol-carbazoles","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/ml400015f","article-title":"Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties","volume":"4","author":"Molette","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib32","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1016\/j.bmcl.2017.08.040","article-title":"Synthesis and biological evaluation of pyridinium-functionalized carbazole derivatives as promising antibacterial agents","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24101912","article-title":"Carbazole derivatives as antiviral agents: an overview","volume":"24","author":"Caruso","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2018.06.022","article-title":"Novel carbazole-triazole conjugates as DNA-targeting membrane active potentiators against clinical isolated fungi","volume":"155","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib35","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1093\/jac\/dkx250","article-title":"In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis","volume":"72","author":"Wang","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib36","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease","volume":"109","author":"De Jesus-Cortes","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib37","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1016\/j.bmc.2013.08.066","article-title":"Aminopropyl carbazole analogues as potent enhancers of neurogenesis","volume":"21","author":"Yoon","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib38","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1039\/C3CS60448A","article-title":"P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases","volume":"43","author":"Pieper","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib39","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.3390\/molecules19079307","article-title":"N-alkyl carbazole derivatives as new tools for Alzheimer's disease: preliminary studies","volume":"19","author":"Saturnino","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1389557515666150709111342","article-title":"Carbazole derivatives: a promising scenario for breast cancer treatment","volume":"16","author":"Caruso","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2174\/1871520615666150113105405","article-title":"Current perspective of natural alkaloid carbazole and its derivatives as antitumor agents","volume":"15","author":"Shaikh","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib42","first-page":"1355","article-title":"Synthesis of some substituted a-carbolines","author":"Stephenson","year":"1970","journal-title":"J. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib43","first-page":"601","article-title":"Synthesis of carbolines by the Graebe-Ullmann method VI. A novel synthesis of 2-Azacarbazole derivative","volume":"41","author":"B\u0119calski","year":"1984","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib44","first-page":"229","article-title":"Synthesis of carbolines by the Graebe-Ullman method. III. Synthesis and inhibiting effect of some derivatives of alpha-carboline","volume":"19","author":"Nantka-Namirski","year":"1962","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib45","first-page":"121","article-title":"Cancerostatics. IV. On the synthesis of some 1-Azacarbazole derivatives as antineoplastic agents","volume":"33","author":"Kaczmarek","year":"1981","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib46","first-page":"331","article-title":"Synthesis of some derivatives of alpha-carboline","volume":"23","author":"Nantka-Namirski","year":"1966","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib47","first-page":"327","article-title":"Structure-activity relationship studies on selected iso-\u03b1-carbolines I Arch","volume":"34","author":"Peczy\u0144ska-Czoch","year":"1986","journal-title":"Immunol. Ther. Exp."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib48","first-page":"1585","article-title":"A convenient synthesis of symmetrical diazacarbazoles","author":"Kaczmarek","year":"1980","journal-title":"Pol. J. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib49","first-page":"269","article-title":"Bipyridines. Part XX. Synthesis and properties of some pyrrolodipyridine anhydronium bases","volume":"35","author":"Kaczmarek","year":"1987","journal-title":"Bull. Pol. Acad. Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","article-title":"Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2217\/nnm-2017-0337","article-title":"Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity","volume":"13","author":"Jaromin","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib55","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/AAC.00536-09","article-title":"Novel antimalarial aminoquinolines: heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes","volume":"53","author":"Omodeo-Sale","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib56","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1248\/bpb.b110671","article-title":"Membrane perturbations induced by new analogs of neocryptolepine","volume":"35","author":"Jaromin","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1208\/pt0804104","article-title":"Nanoemulsions as vehicles for transdermal delivery of aceclofenac","volume":"8","author":"Shakeel","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2015.10.057","article-title":"Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery","volume":"463","author":"Neves","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2174\/138920111798808400","article-title":"Pharmacokinetic concepts revisited--basic and applied","volume":"12","author":"Patel","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib61","first-page":"1135","article-title":"Determination of antiplasmodial activity and binding affinity of selected natural products towards PfTrxR and PfGR","volume":"8","author":"Munigunti","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1550-7408.1965.tb03256.x","article-title":"Pinocytotic uptake and the digestion of hemoglobin in malaria parasites","volume":"12","author":"Rudzinska","year":"1965","journal-title":"J. Protozool."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.88.2.325","article-title":"An iron-carboxylate bond links the heme units of malaria pigment","volume":"88","author":"Slater","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib64","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jinorgbio.2007.12.004","article-title":"Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation","volume":"102","author":"Egan","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0169-4758(86)90051-7","article-title":"Antimalarial schizontocides: ferriprotoporphyrin IX interaction hypothesis","volume":"2","author":"Fitch","year":"1986","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib66","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine's antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib68","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2014.09.007","article-title":"Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence","volume":"29","author":"Rehman","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib69","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib70","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI109925","article-title":"Hemolysis of mouse erythrocytes by ferroprotoporphyrin IX and chloroquine: chemotherapeutic implications","volume":"66","author":"Chou","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0005-2736(83)90219-5","article-title":"The effect of ferriprotoporphyrin IX and chloroquine on phospholipid monolayers and the possible implications to antimalarial activity","volume":"732","author":"Ginsburg","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib72","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.bmc.2005.06.047","article-title":"Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity","volume":"13","author":"Sparatore","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib73","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fct.2014.06.028","article-title":"A review of the nonclinical safety of Transcutol\u00ae, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient","volume":"72","author":"Sullivan","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00049-4","article-title":"Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design","volume":"81","author":"Kawakami","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcis.2007.04.079","article-title":"Oil-in-water nanoemulsions for pesticide formulations","volume":"314","author":"Wang","year":"2007","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-85","article-title":"Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity","volume":"10","author":"Sarr","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib78","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/S0074-02762013000400017","article-title":"In vitro and in vivo antimalarial activity and cytotoxicity of extracts, fractions and a substance isolated from the Amazonian plant Tachia grandiflora (Gentianaceae)","volume":"108","author":"Silva","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib79","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/IJN.S62756","article-title":"Formulation of nanotized curcumin and demonstration of its antimalarial efficacy","volume":"9","author":"Ghosh","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib80","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib81","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1016\/j.bmc.2012.07.041","article-title":"Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl) aminoquinoline","volume":"20","author":"Rusconi","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib82","article-title":"Water\u2010soluble Schiff base Cu(II) and Zn(II) complexes: synthesis, DNA targeting ability and chemotherapeutic potential of Cu(II) complex for hepatocellular carcinoma \u2013 in vitro and in vivo approach","volume":"e3739","author":"Pravin","year":"2017","journal-title":"Appl Organometal. Chem."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2016.05.004","article-title":"Curcumin bioavailability from oil in water nano-emulsions: in vitro and in vivo study on the dimensional, compositional and interactional dependence","volume":"233","author":"Vecchione","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/scipharm85020018","article-title":"The in vitro-in vivo safety confirmation of PEG-40 hydrogenated Castor oil as a surfactant for oral nanoemulsion formulation","volume":"85","author":"Rachmawati","year":"2017","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/bp050208u","article-title":"Role of Caco-2 cell monolayers in prediction of intestinal drug absorption","volume":"22","author":"Shah","year":"2006","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib87","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano7110349","article-title":"Endocytosis of corn oil-caseinate emulsions in vitro: impacts of droplet sizes","volume":"7","author":"Fan","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.foodhyd.2013.07.025","article-title":"The physicochemical stability and in vitro bioaccessibility of beta-carotene in oil-in-water sodium caseinate emulsions","volume":"35","author":"Yi","year":"2014","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib90","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/IJN.S76317","article-title":"Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice","volume":"10","author":"Melariri","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioactmat.2020.10.004_bib91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2007.10.002","article-title":"New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents","volume":"47","author":"M Carballeira","year":"2008","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bioactmat.2020.10.004_bib92","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI115678","article-title":"Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei","volume":"89","author":"Kumaratilake","year":"1992","journal-title":"J. Clin. Invest."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X20302553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X20302553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:52:44Z","timestamp":1762530764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X20302553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2452199X20302553"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2020.10.004","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}